Vista do METABOLIC REPROGRAMMING DRIVEN BY T HE NAD⁺/SIRT1 -PARP1 AXIS: IMPLICATIONS FOR GENOMIC STABILITY, DNA DAMAGE RESPONSE, AND THERAPEUTIC RESISTANCE IN CANCER

Voltar aos Detalhes do Artigo METABOLIC REPROGRAMMING DRIVEN BY T HE NAD⁺/SIRT1 -PARP1 AXIS: IMPLICATIONS FOR GENOMIC STABILITY, DNA DAMAGE RESPONSE, AND THERAPEUTIC RESISTANCE IN CANCER Baixar Baixar PDF